Hologic Financial Statements (HOLX)
|
|
Report date
|
|
|
02.05.2024 |
03.05.2024 |
29.07.2024 |
30.07.2024 |
04.11.2024 |
|
04.11.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 018 |
1 018 |
1 011 |
1 011 |
987.9 |
|
4 029 |
Operating Income, bln rub |
|
|
210.4 |
243.3 |
263.9 |
263.9 |
230.1 |
|
1 001 |
EBITDA, bln rub |
? |
|
210.4 |
317.5 |
336.2 |
344.9 |
328.1 |
|
1 327 |
Net profit, bln rub |
? |
|
169.9 |
169.9 |
194.5 |
194.5 |
178.6 |
|
737.5 |
|
OCF, bln rub |
? |
|
0.000 |
292.4 |
405.8 |
405.8 |
|
|
1 104 |
CAPEX, bln rub |
? |
|
0.000 |
28.0 |
43.9 |
43.9 |
|
|
115.8 |
FCF, bln rub |
? |
|
0.000 |
264.4 |
361.9 |
361.9 |
|
|
988.2 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
|
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
|
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
331.9 |
319.2 |
304.4 |
304.4 |
327.6 |
|
1 256 |
Cost of production, bln rub |
|
|
475.5 |
455.3 |
443.1 |
443.1 |
430.2 |
|
1 772 |
R&D, bln rub |
|
|
74.6 |
74.6 |
64.1 |
64.1 |
67.3 |
|
270.1 |
Interest expenses, bln rub |
|
|
32.3 |
32.3 |
31.9 |
31.9 |
32.0 |
|
128.1 |
|
Assets, bln rub |
|
|
8 714 |
8 714 |
8 890 |
8 890 |
9 156 |
|
9 156 |
Net Assets, bln rub |
? |
|
4 844 |
4 844 |
4 951 |
4 951 |
5 130 |
|
5 130 |
Debt, bln rub |
|
|
2 552 |
2 569 |
2 543 |
2 559 |
2 535 |
|
2 535 |
Cash, bln rub |
|
|
2 180 |
2 180 |
2 439 |
2 439 |
2 334 |
|
2 334 |
Net debt, bln rub |
|
|
371.5 |
388.5 |
104.0 |
120.1 |
201.0 |
|
201.0 |
|
Ordinary share price, rub |
|
|
78.0 |
78.0 |
|
74.3 |
80.8 |
|
66.6 |
Number of ordinary shares, mln |
|
|
235.9 |
235.9 |
234.6 |
234.6 |
233.8 |
|
233.8 |
|
Market cap, bln rub |
|
|
18 390 |
18 390 |
0 |
17 419 |
18 893 |
|
15 560 |
EV, bln rub |
? |
|
18 761 |
18 778 |
104 |
17 539 |
19 094 |
|
15 761 |
Book value, bln rub |
|
|
4 844 |
800 |
4 951 |
972 |
5 130 |
|
5 130 |
|
EPS, rub |
? |
|
0.72 |
0.72 |
0.83 |
0.83 |
0.76 |
|
3.15 |
FCF/share, rub |
|
|
0.00 |
1.12 |
1.54 |
1.54 |
0.00 |
|
4.23 |
BV/share, rub |
|
|
20.5 |
3.39 |
21.1 |
4.14 |
21.9 |
|
21.9 |
|
EBITDA margin, % |
? |
|
20.7% |
31.2% |
33.2% |
34.1% |
33.2% |
|
32.9% |
Net margin, % |
? |
|
16.7% |
16.7% |
19.2% |
19.2% |
18.1% |
|
18.3% |
FCF yield, % |
? |
|
3.72% |
5.16% |
|
5.82% |
4.28% |
|
6.35% |
ROE, % |
? |
|
9.63% |
9.63% |
14.2% |
14.2% |
15.4% |
|
14.4% |
ROA, % |
? |
|
5.35% |
5.35% |
7.89% |
7.89% |
8.62% |
|
8.05% |
|
P/E |
? |
|
39.4 |
39.4 |
0.00 |
24.8 |
23.9 |
|
21.1 |
P/FCF |
|
|
26.9 |
19.4 |
0.00 |
17.2 |
23.4 |
|
15.7 |
P/S |
? |
|
4.64 |
4.64 |
0.00 |
4.37 |
4.69 |
|
3.86 |
P/BV |
? |
|
3.80 |
23.0 |
0.00 |
17.9 |
3.68 |
|
3.03 |
EV/EBITDA |
? |
|
21.3 |
18.1 |
0.09 |
14.4 |
14.7 |
|
11.9 |
Debt/EBITDA |
|
|
0.42 |
0.37 |
0.09 |
0.10 |
0.16 |
|
0.15 |
|
R&D/CAPEX, % |
|
|
|
266.4% |
146.0% |
146.0% |
|
|
233.2% |
|
CAPEX/Revenue, % |
|
|
0.00% |
2.75% |
4.34% |
4.34% |
0.00% |
|
2.87% |
|
Hologic shareholders |